Literature DB >> 25231129

Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.

Xuming Wang1, Xuan Huang1, Zhengqi Fu1, Feng Zou1, Yan Li1, Zhaoyi Wang2, Lijiang Liu1.   

Abstract

To examine the expression patterns of ER-α36 and Cyclin D1 in human gastric cancer tissues and to investigate the effects of ER-α36-mediated estrogen signaling on the growth of gastric cancer cells, 117 samples of formalin-fixed and paraffin-embedded gastric cancer tumor tissues and 40 fresh gastric cancer tumor tissues were analyzed with immunohistochemistry assay and western blot analysis. ER-α36 expression was well correlated with gender (male:female ratio 2.88:1, P=0.01), invasion to serosa (P=0.01) as well as Cyclin D1 expression (P<0.01). The effects of different concentrations of estrogen on the growth of different gastric cancer cells and normal gastric cells as well as gastric cancer SGC7901 cells with different levels of ER-α36 expression were examined. SGC7901 cells with high levels of ER-α36 expression exhibited estrogen hypersensitivity, high growth rate and high levels of Cyclin D1 expression while SGC7901 cells with knocked-down levels of ER-α36 expression were insensitive to estrogen stimulation, grew slowly and expressed less Cyclin D1. Our results indicate that ER-α36 mediates biphasic estrogen signaling in the growth of gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231129     DOI: 10.3892/ijo.2014.2660

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1.

Authors:  Yan-Jie Chen; Li Liang; Jing Li; Hao Wu; Ling Dong; Tao-Tao Liu; Xi-Zhong Shen
Journal:  Dig Dis Sci       Date:  2019-07-26       Impact factor: 3.199

2.  Estrogen receptor-α36-mediated rapid estrogen signaling regulates 78 kDa glucose-regulated protein expression in gastric carcinoma cells.

Authors:  Zhengqi Fu; Xuming Wang; Zhaoyi Wang; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-04-19       Impact factor: 2.967

3.  Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.

Authors:  Kehui Zhang; Jian Wang; YingYing Zhu; Xiaolin Liu; Jiacheng Li; Zhe Shi; Mengxing Cao; Yong Li
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

4.  Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression.

Authors:  Xuming Wang; Qiuyue Chen; Xuan Huang; Feng Zou; Zhengqi Fu; Ying Chen; Yan Li; Zhaoyi Wang; Lijiang Liu
Journal:  Oncol Lett       Date:  2016-11-23       Impact factor: 2.967

5.  Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer.

Authors:  Wenbo Tang; Rujiao Liu; Yan Yan; Xiaoli Pan; Minjun Wang; Xiaotian Han; Hui Ren; Zhe Zhang
Journal:  Oncotarget       Date:  2017-06-20

6.  A Network Pharmacology Study Based on the Mechanism of Citri Reticulatae Pericarpium-Pinelliae Rhizoma in the Treatment of Gastric Cancer.

Authors:  Siyuan Song; Wenjie Huang; Xiaona Lu; Jiatong Liu; Jiayu Zhou; Ye Li; Peng Shu
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-16       Impact factor: 2.629

7.  GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT-Mediated EMT.

Authors:  En Xu; Xuefeng Xia; Chaoyu Jiang; Zijian Li; Zhi Yang; Chang Zheng; Xingzhou Wang; Shangce Du; Ji Miao; Feng Wang; Yizhou Wang; Xiaofeng Lu; Wenxian Guan
Journal:  Front Cell Dev Biol       Date:  2020-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.